TOP STORY
Prostate Cancer: Beta Control Your Hormones
Researchers describe a signaling pathway involving estrogen receptor beta (ERbeta) that governs whether prostate carcinoma cells maintain an epithelial phenotype or undergo epithelial-mesenchymal transition, suggesting that ERbeta would have prognostic or therapeutic value. [Cancer Cell]
|
|
CURRENT PUBLICATIONS
LABORATORY RESEARCH
ER(Beta) Impedes Prostate Cancer EMT by Destabilizing HIF-1(Alpha) and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading
Researchers report that a key function of ER(beta) and its specific ligand 5(alpha)-androstane-3(beta),17(beta)-diol [3(beta)-adiol] is to maintain an epithelial phenotype and repress mesenchymal characteristics in prostate carcinoma. [Cancer Cell]
Immunohistochemical Expression of BRCA1 and Lethal Prostate Cancer
Researchers hypothesized that BRCA1 expression in prostate tumor tissue may be associated with prostate cancer progression through regulation of the cell cycle. [Cancer Res]
ID1 Enhances Docetaxel Cytotoxicity in Prostate Cancer Cells through Inhibition of p21
To identify potential mechanisms underlying prostate cancer chemotherapy response and resistance, researchers compared the gene expression profiles in high-risk human prostate cancer specimens before and after neoadjuvant chemotherapy and radical prostatectomy. [Cancer Res]
Human Carboxypeptidase A4: Characterization of the Substrate Specificity and Implications for a Role in Extracellular Peptide Processing
In the present study, researchers determined that carboxypeptidase A4 is secreted from cells as a soluble proenzyme that can be activated by endoproteases such as trypsin. [J Biol Chem]
Aberrant Activation of the Androgen Receptor by NF-(Kappa)B2/p52 in Prostate Cancer Cells
In the present study, researchers showed that NF-(kappa)B/p52 can activate the androgen receptor (AR), resulting in increased transactivation of AR-responsive genes, such as PSA and NKX3.1, in a ligand-independent manner. [Biochemistry]
Usefulness of the Top-Scoring Pairs of Genes for Prediction of Prostate Cancer Progression
The top-scoring pair approach can be used to identify patients whose prostate cancer will progress after they undergo radical prostatectomy. Two gene pairs can predict which men would experience progression to the metastatic form of the disease. [Prostate Cancer Prostatic Dis]
MicroRNA Let-7a Inhibits Proliferation of Human Prostate Cancer Cells In Vitro and In Vivo by Targeting E2F2 and CCND2
In this study, researchers used in vitro and in vivo approaches to investigate whether E2F2 and CCND2 are direct targets of let-7a, and if let-7a acts as a tumor suppressor in prostate cancer by down-regulating E2F2 and CCND2. [PLoS ONE]
CLINICAL RESEARCH
Risk of Thromboembolic Diseases in Men with Prostate Cancer: Results from the Population-Based PCBaSe Sweden
Researchers investigated the risk of thromboembolic disease in men with prostate cancer who were receiving endocrine treatment, curative treatment, or surveillance. [Lancet Oncol]
Antitumour Activity of MDV3100 in Castration-Resistant Prostate Cancer: A Phase I-II Study
Because growth of castration-resistant prostate cancer is dependent on continued androgen-receptor signalling, researchers assessed the antitumour activity and safety of MDV3100 in men with this disease. [Lancet]
|
|
POLICY NEWS
University of Chicago Physician Named to Presidential Commission for the Study of Bioethical Issues
Daniel Sulmasy, MD, PhD, the Kilbride-Clinton Professor of Medicine and Ethics in the Department of Medicine and the Divinity School, and Associate Director of the MacLean Center for Clinical Medical Ethics at the University of Chicago, has been named to the Presidential Commission for the Study of Bioethical Issues. [Presidential Commission for the Study of Bioethical Issues, United States]
National Human Genome Research Institute Names New Chief of Genome Technology Branch
The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, has named Lawrence C. Brody, Ph.D., as the new chief of its Genome Technology Branch, the largest of seven branches in the NHGRI Division of Intramural Research. [National Institutes of Health, United States]
Minor Use Minor Species Development of Drugs; Research Project Grant (R01) (RFA-FD-10-001) [National Institutes of Health, United States]
Bioengineering Nanotechnology Initiative [STTR (R41/R42)] (PA-10-149) [National Institutes of Health, United States]
Bioengineering Nanotechnology Initiative [SBIR (R43/R44)] (PA-10-150) [National Institutes of Health, United States]
Clinical Investigator Status (Biologics) [Food and Drug Administration, United States]
Background on Study Results of U.S. Academic Researchers [Food and Drug Administration, United States]
Secretary Sebelius Announces Five New Health and Human Services Regional Directors [Department of Health & Human Services, United States]
|
|
EVENTS
American Association for Cancer Research (AACR) 101st Annual Meeting
April 17-21, 2010
Washington, DC, United States
American Urological Association (AUA) 2010 Annual Meeting
May 29-June 3, 2010
San Francisco, United States
International Society for Stem Cell Research (ISSCR) 8th Annual Meeting
June 16-19, 2010
San Francisco, United States
21st Meeting of the European Association for Cancer Research (EACR)
June 26-29, 2010
Oslo, Norway
United Kingdom National Stem Cell Network (UKNSCN) Third Annual Scientific Conference
July 12-14, 2010
Nottingham, United Kingdom
2010 World Cancer Congress
August 18-21, 2010
Shenzhen, China
Joint Annual Meeting of the International Continence Society (ICS) and International Urogynecological Association (IUGA)
August 23-27, 2010
Toronto, Canada
28th World Congress of Endourology and SWL
September 1-4, 2010
Chicago, United States
35th European Society for Medical Oncology (ESMO) Congress
October 8-12, 2010
Milan, Italy
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES Sr. Product Support and Training Specialist (CardianBCT)
Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News.
Visit here to post your career opportunities.
Have we missed an important article or publication in Prostate Cell News? Click here to submit!
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
